Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
221 studies found for:    Open Studies | "liver transplantation"
Show Display Options
Rank Status Study
1 Recruiting Liver Resection Versus Radio-chemotherapy-Transplantation for Hilar Cholangiocarcinoma
Conditions: Cholangiocarcinoma;   Morphological Diagnosis of Hilar Cholangiocarcinoma (Excluded Type 1), Resectable With Expected R0 Margins on an intent-to Treat Basis.
Interventions: Procedure: CAPECITABINE-Radiotherapy -Liver Transplantation;   Procedure: RESECTION
2 Recruiting Anesthetic Methods and Liver Transplantation
Condition: Acute Lung Injury
Interventions: Drug: propofol during liver transplantation.;   Drug: Desflurane during liver transplantation.
3 Recruiting Liver Transplantation in Patients With Unresectable Colorectal Liver Metastases Treated by Chemotherapy
Conditions: Liver Metastasis;   Colorectal Cancer;   Metastasis
Intervention: Procedure: Liver Transplantation
4 Recruiting Donor-Alloantigen-Reactive Regulatory T Cell (darTregs) in Liver Transplantation
Condition: Liver Transplantation
Interventions: Biological: Anti-Thymocyte Globulin - Rabbit;   Biological: darTreg Infusion;   Drug: Everolimus;   Drug: Tacrolimus;   Drug: Mycophenolate mofetil;   Drug: Prednisone;   Drug: Acetaminophen;   Drug: Diphenhydramine;   Drug: Anti-Infective Prophylaxis;   Procedure: Leukapheresis;   Procedure: Blood draws;   Procedure: Liver biopsies;   Procedure: Liver transplantation
5 Recruiting Sequential, Related Donor Partial Liver Transplantation Followed by Bone Marrow Transplantation for Hepatocellular Carcinoma (HCC)
Conditions: Fibrolamellar Hepatocellular Carcinoma;   Hepatocellular Carcinoma (Fibrolamellar Variant);   Hepatocellular Carcinoma
Interventions: Procedure: living related donor partial liver transplantation;   Radiation: Total body irradiation;   Procedure: Bone marrow transplant from same donor;   Drug: Cyclophosphamide;   Drug: Mesna;   Drug: Filgrastim;   Drug: Tacrolimus;   Drug: mycophenolate mofetil;   Drug: Prednisone;   Drug: Antithymocyte globulin;   Drug: fludarabine
6 Not yet recruiting Liver Transplantation for Early Intrahepatic Cholangiocarcinoma
Condition: Intrahepatic Cholangiocarcinoma
Intervention: Procedure: Deceased donor Liver Transplantation
7 Recruiting Safety Study of Liver Transplantation for Hilar Cholangiocarcinoma
Condition: Hilar Cholangiocarcinoma
Intervention: Other: liver transplantation combined with neoadjuvant therapy
8 Unknown  Expansion of Conventional Criteria for Liver Transplantation in Hepatocellular Carcinoma Through Downstaging
Conditions: Carcinoma, Hepatocellular;   Cirrhosis
Intervention: Procedure: Liver transplantation
9 Recruiting Living Donor Liver Transplantation for Unresectable Colorectal Cancer Liver Metastases
Conditions: Colorectal Cancer;   Liver Metastases
Intervention: Procedure: live donor liver transplantation
10 Recruiting Liver Transplantation and Colorectal Cancer
Conditions: Colorectal Cancer;   Liver Metastasis
Intervention: Procedure: Liver transplantation and liver resection
11 Unknown  Liver Transplantation for Hilar Cholangiocarcinoma in Association With Neoadjuvant Radio- and Chemo-therapy
Conditions: Hilar Cholangiocarcinoma;   Primary Sclerosing Cholangitis
Interventions: Procedure: Liver transplantation;   Radiation: 45 Gy external radiations;   Radiation: Endoluminal bile duct Brachytherapy;   Drug: Capecitabine;   Procedure: Pre liver transplantation laparoscopic hand assisted staging
12 Recruiting Neo-adjuvant Peptide Receptor Mediated Radiotherapy With 177Lutetium in Front of Curative Intended Liver Transplantation in Patients With Hepatic Metastasis of Neuroendocrine Tumors (NEO-LEBE)
Conditions: Liver;   Metastasis;   Neuroendocrine Tumors
Interventions: Radiation: 177Lutetium;   Procedure: Liver transplantation
13 Recruiting Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer
Conditions: PRETEXT Stage 1 Hepatoblastoma;   PRETEXT Stage 2 Hepatoblastoma;   PRETEXT Stage 3 Hepatoblastoma;   PRETEXT Stage 4 Hepatoblastoma
Interventions: Drug: Cisplatin;   Drug: Doxorubicin Hydrochloride;   Drug: Fluorouracil;   Drug: Irinotecan Hydrochloride;   Other: Laboratory Biomarker Analysis;   Procedure: Liver Transplantation;   Drug: Temsirolimus;   Procedure: Therapeutic Conventional Surgery;   Drug: Vincristine Sulfate
14 Recruiting Immunosuppressive Therapy Optimization: Development of a Population Pharmacokinetic-pharmacodynamic (PK-PD) Model in Liver Transplantation
Condition: Liver Transplantation
Intervention: Other: Pharmacokinetic-pharmacodynamic model in liver transplantation
15 Unknown  Prediction of Mortality in Patients Waiting for Liver Transplantation Through Brain Magnetic Resonance Imaging
Conditions: End Stage Liver Disease;   Hepatic Encephalopathy
Intervention:
16 Recruiting Predictions of Bleeding During Liver Transplantation With Thromboelastometry
Condition: Hemorrhage
Intervention: Other: ROTEM analysis
17 Recruiting Institutional Registry of Liver Transplantation
Conditions: Liver Transplantation;   Clinical Registry
Intervention: Procedure: orthotopic liver transplantation
18 Not yet recruiting SVC and Its Relationship to CVP Measurements in Liver Transplantation
Condition: Liver Failure
Intervention: Procedure: Liver Transplant
19 Recruiting Evolution and Clinical Outcomes in Patients Undergoing Liver Transplantation
Conditions: Liver Disease;   Nutrition Disorders
Intervention:
20 Recruiting Safety Study of Multipotent Progenitor Cells for Immunomodulation Therapy After Liver Transplantation
Condition: Liver Transplantation
Intervention: Drug: MultiStem

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years